Загрузка...
Recent Findings in the Posttranslational Modifications of PD-L1
Immune checkpoint therapy, such as the reactivation of T-cell activity by targeting programmed cell death 1 (PD-1) and its ligand PD-L1 (also called B7-H1 and CD274) has been found pivotal in changing the historically dim prognoses of malignant tumors by causing durable objective responses. However,...
Сохранить в:
| Опубликовано в: : | J Oncol |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7199566/ https://ncbi.nlm.nih.gov/pubmed/32377193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5497015 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|